Literature DB >> 30374622

A multicenter observational study on the clinicopathological features of gastric cancer in young patients.

Yoshiyasu Kono1, Hiromitsu Kanzaki2, Takao Tsuzuki3, Masahiro Takatani3, Junichirou Nasu4, Daisuke Kawai5, Ryuta Takenaka5, Takehiro Tanaka6, Masaya Iwamuro2, Seiji Kawano2, Yoshiro Kawahara7, Toshiyoshi Fujiwara8, Hiroyuki Okada2.   

Abstract

BACKGROUND: The details of gastric cancer in young patients remain unclear because of the low prevalence of the disease. This study aimed to clarify the clinicopathological features and prognosis of gastric cancer in young patients.
METHODS: From January 2007 to January 2016, patients in their 20s and 30s who were diagnosed with primary gastric cancer at 4 hospitals were enrolled. Their clinical characteristics and prognosis were evaluated.
RESULTS: The total number of patients was 72. The median age was 36 years, and the ratio of males to females was 1:1. The dominant histological type was undifferentiated type (66/72, 92%). Helicobacter pylori (H. pylori) was positive in 81% (54/67). Although there were some asymptomatic patients in stages I-III, all stage IV patients had some clinical symptoms at the diagnosis. The percentage of stage IV was significantly higher in patients in their 20s than in those in their 30s (75% vs. 25%, P < 0.001). The Kaplan-Meier method showed that the overall survival of patients in their 20s was significantly lower than that of patients in their 30s (P = 0.037).
CONCLUSIONS: A high rate of H. pylori infection was revealed in young gastric cancer patients. The patients in their 20s had a worse prognosis than those in their 30s. We should consider examining the H. pylori infection status for young patients as well as older patients to identify high-risk populations.

Entities:  

Keywords:  Gastric cancer; Helicobacter pylori; Young patient

Mesh:

Substances:

Year:  2018        PMID: 30374622     DOI: 10.1007/s00535-018-1525-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  25 in total

1.  Clinicopathological comparison between young and old age patients with gastric adenocarcinoma.

Authors:  Kamal E Bani-Hani
Journal:  Int J Gastrointest Cancer       Date:  2005

2.  Intramucosal gastric adenocarcinoma of poorly differentiated type in the young is characterized by Helicobacter pylori infection and antral lymphoid hyperplasia.

Authors:  Minako Hirahashi; Takashi Yao; Takayuki Matsumoto; Ken-Ichi Nishiyama; Masafumi Oya; Mitsuo Iida; Masazumi Tsuneyoshi
Journal:  Mod Pathol       Date:  2006-10-13       Impact factor: 7.842

3.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

4.  Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.

Authors:  S Kikuchi; J E Crabtree; D Forman; M Kurosawa
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

5.  Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients.

Authors:  J B Koea; M S Karpeh; M F Brennan
Journal:  Ann Surg Oncol       Date:  2000-06       Impact factor: 5.344

6.  Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients.

Authors:  K Haruma; K Komoto; T Kamada; M Ito; Y Kitadai; M Yoshihara; K Sumii; G Kajiyama
Journal:  Scand J Gastroenterol       Date:  2000-03       Impact factor: 2.423

7.  Clinicopathological features of gastric carcinoma in younger and middle-aged patients: a comparative study.

Authors:  Chikara Kunisaki; Hirotoshi Akiyama; Masato Nomura; Goro Matsuda; Yuichi Otsuka; Hidetaka Andrew Ono; Ryo Takagawa; Yutaka Nagahori; Masazumi Takahashi; Fumihiko Kito; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

8.  Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.

Authors:  Masayuki Tatemichi; Shizuka Sasazuki; Manami Inoue; Shoichiro Tsugane
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

9.  Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer.

Authors:  Daniele Marrelli; Corrado Pedrazzani; Anna Berardi; Giovanni Corso; Alessandro Neri; Lorenzo Garosi; Carla Vindigni; Annalisa Santucci; Natale Figura; Franco Roviello
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

10.  Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients.

Authors:  Jan Kulig; Tadeusz Popiela; Piotr Kolodziejczyk; Marek Sierzega; Joanna Jedrys; Antoni M Szczepanik
Journal:  Langenbecks Arch Surg       Date:  2007-07-06       Impact factor: 3.445

View more
  4 in total

1.  A validated survival nomogram for early-onset diffuse gastric cancer.

Authors:  Fei Liao; Xufeng Guo; Xiaohong Lu; Weiguo Dong
Journal:  Aging (Albany NY)       Date:  2020-07-08       Impact factor: 5.682

2.  Evaluating and validating the predictive ability of preoperative systemic inflammatory/immune cells in gastric cancer following R0 resection.

Authors:  Wenbo Xue; Xuezhong Xu; Yulin Tan; Yan Qian; Hao Wang; Yibo Wang; Yixin Xu; Xiaojun Zhu; Peng Jiang; Wei Ding
Journal:  Oncol Lett       Date:  2019-09-13       Impact factor: 2.967

3.  Different Incidence of Early-Onset Gastric Carcinoma Depending on Ethnicity: Preliminary Results of a Hospital in Liangshan.

Authors:  Shen Li; Peter Rexin; Zhang Qin; Chen Changbo; Chen Guanghui; Wang Luyao; Hans-Ullrich Voelker; Gerhard Stauch
Journal:  ScientificWorldJournal       Date:  2020-03-10

4.  Evaluation and validation of the prognostic value of nutrition and immunity parameters in gastric cancer after R0 resection.

Authors:  Wenbo Xue; Xuezhong Xu; Yulin Tan; Yibo Wang; Hao Wang; Yixin Xu; Cheng Xi; Peng Jiang; Wei Ding
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.